Evaluation of the general practice research database congenital heart defects prevalence: Comparison to United Kingdom national systems

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 79, Issue 4, 2007, Pages 309-316

  Wurst, Keele E ^a,b   Ephross, Sara A ^b   Loehr, James ^a   Clark, Douglas W ^b   Guess, Harry A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Congenital heart defects; GPRD; Prevalence; Specific heart defects

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; DATA BASE; EUROPEAN CONCERTED ACTION OF CONGENITAL ANOMALIES AND TWINS; GENERAL PRACTICE; GENERAL PRACTICE RESEARCH DATABASE; HUMAN; NATIONAL CONGENITAL ANOMALY SYSTEM; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM; VALIDATION PROCESS; CHILD; EUROPE; EVALUATION; FACTUAL DATABASE; INFANT; NEWBORN; PRESCHOOL CHILD; REGISTER; STANDARD;

CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; EUROPE; FAMILY PRACTICE; GREAT BRITAIN; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; PREVALENCE; REGISTRIES;

EID: 34250840515     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20356     Document Type: Article

References (31)

1. Andrade S, Gurwitz JH, Davis RL, et al. 2004. Prescription Drug Use in Pregnancy. Am J Obstet Gynecol 191:398-407.
2. Baron AM, Donnerstein RL, Kanter E, et al. 2001. Congenital heart disease in the Medicaid population of Southern Arizona. Am J Cardiol 88:462-465.
3. Bosi G, Garani G, Scorrano M, et al. 2003. Temporal variability in birth prevalence of congenital heart defects as recorded by a general birth defects registry. J Pediatr 142:690-698.
4. Botto LD, Correa A, Erickson JD. 2001. Racial and Temporal Variations in the Prevalence of Heart Defects. Pediatrics 107:1-8.
5. Boyd P, Armstrong B, Dolk H, et al. 2005. Congenital Anomaly Surveillance In England - Ascertainment Deficiencies in the National System. BMJ 330:27.
6. Briggs G, Freeman R, Yaffe S. 2002. Drugs in Pregnancy and Lactation. New York: Lippincott Williams & Wilkins. pp 1-682.
7. Bull C. 1999. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 354:1242-1247.
8. Calzolari E, Garani G, Cocchi G, et al. 2003. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol 18:773-780.
9. Canger R, Battino D, Canevini MP, et al. 1999. Malformations in offspring of women with epilepsy: a prospective study. Epilepsia 40:1231-1236.
10. Dolk H. 2005. EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Edition 90:F355-358.
11. EUROCAT. 2003. 1980-2002 Prevalence Data Tables, Congenital heart defects 2001 from all full member registries. www.eurocat.ulster.ac.uk/whatis.html, last accessed August 2003.
12. EUROCAT. 2005a. Definition of Congenital Anomaly Subgroups with Comments on Surgery and Age at Diagnosis. http://www.eurocat.ulster.ac.uk/pubdata/ Publications.html#EUROCAT%20Coding%20Guides, last accessed January 2006.
13. EUROCAT. 2005b. Guide 1.3 and reference documents Instructions for the Registration and Surveillance of Congenital Anomalies. EUROCAT Central Registry: Northern Ireland UK. http://www.eurocat.ulster.ac.uk/pubdata/Publications. html#EUROCAT%20Coding%20Guides, last accessed November 2005.
14. EUROCAT. 2006. EUROCAT Full Member Registry Descriptions. http://eurocat.ulster.ac.uk/memberreg/memberreg.html, last accessed October 2006.
15. Garcia-Rodriguez L, Perez-Gutthan S, Jick S. 2000. The UK General Practice Research Database. In: Strom B, editor. Pharmacoepidemiology. New York: John Wiley and Sons. p. 375-382.
16. Garne E. 2004. Congenital Heart Defects-occurrence, surgery, and prognosis in a Danish Country. Scand Cardiovasc J 38:357-362.
17. Hoffman JI, Kaplan S. 2002. The Incidence of Congenital Heart Disease. J Am Coll Cardiol 39:1890-1900.
18. Honein MA, Paulozzi LJ. 1999. Birth defects surveillance: assessing the "gold standard". Am J Public Health 89:1238-1240.
19. Honein MA, Paulozzi LJ, Cragan JD, et al. 1999. Evaluation of selected characteristics of pregnancy drug registries. Teratology 60:356-364.
20. Kochanek KD, Smith BL. 2004. Deaths: Preliminary data for 2002. National vital statistics reports; vol 52 no 13. Hyattsville, MD: National Center for Health Statistics. Available from http://www.cdc.gov/nchs/data/nvsr/nvsr52/ nvsr52_13.pdf.
21. MACDP. 2002. Report on the Metropolitan Atlanta Congenital Defect Program. 1996-1999. Available from http://origin.cdc.gov/ncbddd/bd/documents/ MACDP2002.pdf.
22. McEvoy G. 2004. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists.
23. Meberg A, Otterstad JE, Froland G, et al. 1999. Early clinical screening of neonates for congenital heart defects: the cases we miss. Cardiol Young 9:169-174.
24. Misra T, Dattani N, Majeed A. 2006. Congenital anomaly surveillance in England and Wales. Public Health 120:256-264.
25. Office of National Statistics. 2001. Congenital Anomaly Statistics Notifications England and Wales summary table. www.statistics.gov.uk/CCI, last accessed August 2003
26. Office of National Statistics. 2005a. Babies notified to National Congenital Anomaly System (NCAS) by selected cardiovascular condition, England and Wales, 2001-2003. London.
27. Office of National Statistics. 2005b. Moves within the UK. 2001 Census, Individual Sample of Anonymised Records-Office for National Statistics; General Register Office for Scotland; Northern Ireland Statistics and Research Agency. http://www.statistics.gov.uk/cci/nugget.asp?id-1310, last accessed October 2006.
28. Pradat P, Francannet C, Harris JA, et al. 2003. The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol 24:195-221.
29. Samanek M, Voriskova M. 1999. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol 20:411-417.
30. Wood L, Coulson R. 2001. Revitalizing the General Practice Research Database: plans, challenges, and opportunities. Pharmacoepidemiol Drug Saf 10:379-383.
31. Wren C, Richmond S, Donaldson L. 2000. Temporal variability in birth prevalence of cardiovascular malformations. Heart 83:414-419.